Skip to main content

Bioactive Compounds from Food and Their Applications in the Treatment of Type 2 Diabetes

  • Chapter
  • First Online:
Sustainable Food Innovation

Part of the book series: Sustainable Development Goals Series ((SDGS))

  • 437 Accesses

Abstract

The occurrence of insulin and glucose metabolism disorders (collectively referred to as Diabetes), are increasing globally with expectations that over 700 million individuals will be diagnosed with Type 2 Diabetes by 2025. Current treatments for Type 2 Diabetes are limited by the side effects they impose on patients as well as the practical ability to resolve all aspects of the illness. Therefore, there is a need to develop new treatment approaches. Bioactive compounds derived from foods including, phenolic compounds, alkaloids, and bioactive peptides, have been shown to have potential as treatments for Type 2 Diabetes. Mechanisms of action for bioactive compounds derived from foods against Type 2 Diabetes include α-amylase and α-glucosidase inhibition, incretin hormone modulation, and modulation of insulin receptors (both expression and sensitivity). Before there use, bioactive compounds require concentration, extraction, and (or) purification from the original source. The protein fraction of food waste, especially animal-based foods, can also be used as a substrate for the generation of bioactive peptides or as a source of enzymes that can be subsequently used for the generation of bioactive peptides. Waste derived from plant based food systems, is known to be especially rich in phenolic compounds and alkaloids. When extracted using modern processing methods such as microwave assisted extraction or Pulsed electric field, plant based food waste can be seen as a sustainable source of these compounds. This chapter explores selected bioactive compounds found in food and evaluates them in the context of the treatment of Type 2 Diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

DPPH:

2,2-diphenyl-1-picrylhydrazyl radical scavenging capacity

ORAC:

oxygen radical absorbance capacity

PEF:

pulsed electric field

HPLC:

high-performance liquid chromatography

UPLC:

ultra-performance liquid chromatography

Da:

Dalton

GLP-1:

glucagon-like peptide-1

GIP:

gastric inhibitory polypeptide

DPP-IV:

Dipeptidyl peptidase-IV

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Keegan Burrow .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Burrow, K., Fletcher, S., Lee, H., Serventi, L. (2023). Bioactive Compounds from Food and Their Applications in the Treatment of Type 2 Diabetes. In: Serventi, L. (eds) Sustainable Food Innovation . Sustainable Development Goals Series. Springer, Cham. https://doi.org/10.1007/978-3-031-12358-0_9

Download citation

Publish with us

Policies and ethics